| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-15 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-11 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.26 | 5e-10 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.21 | 7e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.2 | 8e-08 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-07 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |